Key result
The combined treatment of quercetin and doxorubicin reduced the average tumor weight of liver cancer xenografts to compared to with doxorubicin alone.
Why the study?
Does quercetin improve doxorubicin-mediated antitumor effects and prevent hepatotoxicity in liver cancer models?
Does quercetin improve doxorubicin-mediated antitumor effects and prevent hepatotoxicity in liver cancer models?
Quercetin potentiates the antitumor efficacy of doxorubicin against liver cancer while protecting against doxorubicin-induced hepatotoxicity in preclinical models.
Answers are grounded in this paper and cite their sources.
Supports preclinical testing of quercetin-doxorubicin combinations in liver cancer; leaves open clinical translation.
BACKGROUND: The dose-dependent toxicities of doxorubicin (DOX) limit its clinical applications, particularly in drug-resistant cancers, such as liver cancer. In this study, we investigated the role of quercetin on the antitumor effects of DOX on liver cancer cells and its ability to provide protection against DOX-mediated liver damage in mice. METHODOLOGY AND RESULTS: The MTT and Annexin V/PI staining assay demonstrated that quercetin selectively sensitized DOX-induced cytotoxicity against liver cancer cells while protecting normal liver cells. The increase in DOX-mediated apoptosis in hepatoma cells by quercetin was p53-dependent and occurred by downregulating Bcl-xl expression. Z-VAD-fmk (caspase inhibitor), pifithrin-α (p53 inhibitor), or overexpressed Bcl-xl decreased the effects of quercetin on DOX-mediated apoptosis. The combined treatment of quercetin and DOX significantly reduced the growth of liver cancer xenografts in mice. Moreover, quercetin decreased the serum levels of alanine aminotransferase and aspartate aminotransferase that were increased in DOX-treated mice. Quercetin also reversed the DOX-induced pathological changes in mice livers. CONCLUSION AND SIGNIFICANCE: These results indicate that quercetin potentiated the antitumor effects of DOX on liver cancer cells while protecting normal liver cells. Therefore, the development of quercetin may be beneficial in a combined treatment with DOX for increased therapeutic efficacy against liver cancer.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2012) studied Liver Cancer. Quercetin and Doxorubicin vs. Doxorubicin alone was evaluated on Average tumor weight (p=<0.001). The combined treatment of quercetin and doxorubicin reduced the average tumor weight of liver cancer xenografts to compared to with doxorubicin alone.
Synapse has enriched 10 related papers. Consider them for comparative context: